AI-Powered Drug Discovery · Rare Oncology
Designing medicines for
rare cancers
with agentic AI as your copilot.
Siloam orchestrates specialized AI agents — from target discovery to lead optimization — with human scientists in the loop at every step. Not a black-box oracle. A transparent copilot for the hardest patient populations.
2
Active programs
17d
In-silico discovery cycle
100%
Human-in-the-loop
1
Focus · Rare Oncology
01 · How We're Different
Agentic AI as a copilot —
not a black box.
Most AI-drug-discovery platforms hand you a scored candidate list and ask you to trust it. drug.AI hands your medicinal chemists a research partner they can inspect, question, and steer at every gate.
Copilot Guarantee
0%
Human-reviewed candidates. No prediction ever ships without a scientist's sign-off.
12Autonomous agents
6Human review gates
0Un-validated candidates
◉ Siloam · drug.AI Copilot
Human-in-the-loop
at every decision.
at every decision.
- Every candidate carries a full provenance chain — every score, rejection, and human override preserved.
- Scientists inspect the reasoning graph and veto agents in real time — the system learns from every intervention.
- Compliance-by-design: regulatory readiness baked into every model and dataset from day one.
- Efficacy is measured against wet-lab ground truth on every program — predictions never ship un-validated.
- Agents argue with each other. Disagreement is a feature — you see the debate before the answer.
VS
⚠ Black-Box AI
Opaque predictions.
Unclear efficacy.
Unclear efficacy.
- Ranked candidate list handed off — no way to inspect why the model chose it.
- No mechanism to override or steer without retraining the whole model.
- Regulatory trail is an afterthought — bolted on before IND, not designed in.
- Retrospective benchmarks over prospective validation — the paper looks great; the clinic doesn't.
- One monolithic model. When it's wrong, you can't tell where the failure lives.
"We're not building a prediction engine. We're building a research partner our medicinal chemists can argue with — one that gets better with every wet-lab result and every human override."
— Dr. Dony Ang, CEO / CTO / Co-founder04 · Partner With Us